What is Kapil Mayawala email address?

Kapil Mayawala's primary email address is **************@merck.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kapil Mayawala work for?

Kapil Mayawala is a Vice President, Clinical Pharmacology, Clinical Development at Generate:Biomedicines, a company specializing in Commercial physical research.

Where Kapil Mayawala graduated from?

Kapil Mayawala holds a degree in from University of Chicago.

How can I directly contact Kapil Mayawala?

To contact Kapil Mayawala directly, you can use the email address **************@merck.com. Complete contact information is available upon registration with Muraena.

Is Kapil Mayawala an immigrant?

Yes, Kapil Mayawala is an immigrant and currently based in United States

Who is Kapil Mayawala?

Kapil Mayawala is a seasoned professional in the pharmaceutical and medicine manufacturing industry, currently serving as Vice President of Clinical Pharmacology and Clinical Development at Generate Biomedicines. With extensive experience in oncology research and development, he possesses deep expertise in biologics and has played pivotal roles in various stages of drug development, from discovery to regulatory filings. His leadership at Merck involved overseeing oncology assets and contributing to critical FDA filings for Keytruda. Kapil's academic background includes prestigious institutions such as the University of Chicago and IIT Kanpur, complemented by a strong publication record in oncology-related topics. He is passionate about advancing drug development methodologies and is recognized for his contributions to improving clinical trial designs. His work is characterized by a commitment to innovation and a data-driven approach, particularly in the context of immuno-oncology. Kapil's professional journey reflects a blend of strategic insight and scientific rigor, making him a notable leader in his field.